GSK Overview

  • Status
  • Public

  • Employees
  • 68,629

Employees

  • Stock Symbol
  • GSK

Stock Symbol

  • Investments
  • 148

  • Share Price
  • $18.72
  • (As of Monday Closing)

GSK General Information

Description

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Contact Information

Website
www.gsk.com
Formerly Known As
GlaxoSmithKline
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 980 Great West Road
  • Brentford
  • Middlesex TW8 9GS
  • England, United Kingdom
+44 020
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
LON
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • 980 Great West Road
  • Brentford
  • Middlesex TW8 9GS
  • England, United Kingdom
+44 020

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GSK Stock Performance

As of 28-Apr-2025, GSK’s stock price is $18.72. Its current market cap is $75.8B with 4.05B shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$18.72 $18.51 $15.77 - $23.14 $75.8B 4.05B 10.7M $0.81

GSK Financials Summary

As of 31-Mar-2025, GSK has a trailing 12-month revenue of $40.2B.

In Thousands,
USD 		TTM 31-Mar-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 92,794,310 85,392,295 91,541,122 87,164,139
Revenue 40,210,945 40,089,952 37,698,886 36,140,896
EBITDA 9,704,243 8,443,218 11,230,857 10,562,252
Net Income 4,021,222 3,290,146 6,125,696 18,432,794
Total Assets 78,534,743 74,613,213 75,166,563 72,788,663
Total Debt 23,845,686 21,313,759 22,953,159 25,398,458
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GSK Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GSK‘s full profile, request access.

Request a free trial

GSK Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might acros
Pharmaceuticals
Middlesex, United Kingdom
68,629 As of 2024

Cambridge, United Kingdom
 

Basel, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GSK Competitors (36)

One of GSK’s 36 competitors is AstraZeneca, a Formerly PE-Backed company based in Cambridge, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AstraZeneca Formerly PE-Backed Cambridge, United Kingdom
Novartis Corporation Basel, Switzerland
Merck & Co. Corporation Rahway, NJ
Pfizer (Pharmaceuticals) Corporation New York, NY
Eli Lilly and Company Corporation Indianapolis, IN
You’re viewing 5 of 36 competitors. Get the full list »

GSK Patents

  • 43,779

    Total Documents Applications and Grants

  • Total Patents Families

  • 11,897

    Granted

  • 5,337

    Pending

  • Expiring in next 12 mo

GSK Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202418241-D0 Biopolymers for encapsulation Pending 12-Dec-2024
GB-202414861-D0 Novel uses Pending 09-Oct-2024
GB-202414530-D0 Nucleic acid based vaccine Pending 03-Oct-2024
GB-202409218-D0 Hepatitis b compositions Pending 26-Jun-2024
GB-202404607-D0 Rna formulation Pending 29-Mar-2024 A61K9/0019
To view GSK’s complete patent history, request access »

GSK Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GSK Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GSK‘s full profile, request access.

Request a free trial

GSK Investments & Acquisitions (148)

GSK’s most recent deal was a Merger/Acquisition with IDRx for . The deal was made on 21-Feb-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
IDRx 21-Feb-2025 Merger/Acquisition Drug Discovery
CELLphenomics 15-Jan-2025 Merger/Acquisition Discovery Tools (Healthcare)
Ouro Medicines 10-Jan-2025 Early Stage VC Biotechnology
Relation 11-Dec-2024 Seed Round Drug Discovery
Chimagen Biosciences (CMG1A46 Based in Chengdu, China) 29-Oct-2024 Corporate Asset Purchase Buildings and Property
You’re viewing 5 of 148 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

GSK ESG

Risk Overview

Risk Rating

Updated November, 02, 2024

15.02 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 15,109

Rank

Percentile

Pharmaceuticals

Industry

of 861

Rank

Percentile

Pharmaceuticals

Subindustry

of 430

Rank

Percentile

To view GSK’s complete esg history, request access »

GSK Exits (67)

GSK’s most recent exit was on 13-Dec-2022 from WaVe Life Sciences. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
WaVe Life Sciences 13-Dec-2022 Completed
CalciMedica 11-Mar-2021 Completed
  • 10 buyers
Insmed Innovation 18-Dec-2020 Completed
  • 2 buyers
IDEAYA Biosciences 03-Aug-2020 Completed
Haleon 31-Jul-2019 Joint Venture Completed
  • 2 buyers
You’re viewing 5 of 67 exits. Get the full list »

GSK Affiliates

Subsidiaries (27)

Name Industry Location Year Founded
IDRx Plymouth, MA 2021
Tesaro Bio Netherlands Duivendrecht, Netherlands 2016
Galvani Bioelectronics Stevenage, United Kingdom 2016
CELLphenomics Berlin, Germany 2014
Action Potential Venture Capital Cambridge, MA 2013
You’re viewing 5 of 27 affiliates. Get the full list.  »

GSK FAQs

  • Where is GSK headquartered?

    GSK is headquartered in Middlesex, United Kingdom.

  • What is the size of GSK?

    GSK has 68,629 total employees.

  • What industry is GSK in?

    GSK’s primary industry is Pharmaceuticals.

  • Is GSK a private or public company?

    GSK is a Public company.

  • What is GSK’s stock symbol?

    The ticker symbol for GSK is GSK.

  • What is the current stock price of GSK?

    As of 28-Apr-2025 the stock price of GSK is $18.72.

  • What is the current market cap of GSK?

    The current market capitalization of GSK is $75.8B.

  • What is GSK’s current revenue?

    The trailing twelve month revenue for GSK is $40.2B.

  • Who are GSK’s competitors?

    AstraZeneca, Novartis, Merck & Co., Pfizer (Pharmaceuticals), and Eli Lilly and Company are some of the 36 competitors of GSK.

  • What is GSK’s annual earnings per share (EPS)?

    GSK’s EPS for 12 months was $0.81.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »